If you’re someone with a big chunk of money in the stock market right now, you’re probably pretty happy with the state of ...

After a record year in 2024, where companies raised ₹1.36 lakh crore through the QIP route, the figure has seen a dip this ...

ADHD medications work like sleep, not attention boosters, massive brain study reveals. For some kids, focus problems may be ...

Biohaven shares fell 16.19% in after-hours trading Wednesday after its Phase 2 depression drug trial missed the primary ...

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

Before buying shares in family-run businesses, it behoves one to dig deeper into the family succession plan than just reading the securities documents — because family is not in the prospectus.

Mental health has moved from the margins to the center of the global healthcare conversation. Rising anxiety, depression, and ...

Atrial fibrillation, the dangerous heart rhythm disorder commonly referred to as A-fib, affects more than 10 million U.S. adults. Even with so many people affected, doctors have been stuck with the ...